Edition:
India

Profile: Caplin Point Laboratories Ltd (CAPL.BO)

CAPL.BO on Bombay Stock Exchange

1,307.10INR
30 Sep 2016
Change (% chg)

Rs33.15 (+2.60%)
Prev Close
Rs1,273.95
Open
Rs1,296.55
Day's High
Rs1,314.95
Day's Low
Rs1,281.50
Volume
986
Avg. Vol
3,086
52-wk High
Rs1,582.00
52-wk Low
Rs835.25

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and Ovules, Powder for Injection, Dry syrup, Topicals, Liquid Injections, Inhalers, intravenous (IV) Infusion, Lyophilized Products, Branded Products, Dermo Cosmetics and Other Products. It also manufactures a range of ointments, creams, gels and lotions. The Company has presence in Latin American nations of Guatemala, Honduras, Nicaragua, El Salvador, Ecuador, Honduras, Venezuela and Dominican Republic. The Company's manufacturing facilities are located in Suthukeny village, Puducherry; Gummidipoondi Taluk, Tamil Nadu, and Baddi, Himachal Pradesh. Its research and development units are located in Gummidipoondi Taluk, Tamil Nadu.

Company Address

Caplin Point Laboratories Ltd

NARBAVI
No. 3, Lakshmanan Street, T. Nag
CHENNAI     600017
P: +9144.28156653
F: +9144.28154952

Company Web Links